Laboratoires Delbert
FranceWho owns Laboratoires Delbert?
Laboratoires Delbert is a French Pharma company, currently owned by Idia since 2023 and 2 other investors. It changed hands in 2023, when Sagard sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Idia, Vivalto Partners and Socadif since 2023.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected · 1 lender on file
Sagard sold Laboratoires Delbert to Vivalto Partners in 2023 after 1 year.
More from Vivalto Partners Fund I
Other portfolio companies in the same fund.
Switzerland
More PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Laboratoires Delbert?
Laboratoires Delbert is currently owned by Idia, Vivalto Partners and 1 other, through Vivalto Partners Fund I, since 2023.
When did Idia and 2 others acquire Laboratoires Delbert?
Idia and 2 others acquired Laboratoires Delbert in 2023.
Who did Laboratoires Delbert sell to?
Sagard sold Laboratoires Delbert to Vivalto Partners in 2023 (Recapitalization).
Who has owned Laboratoires Delbert over time?
Laboratoires Delbert has been through 5 private-equity ownership periods: Sagard · via Sagard · 2022–2023 · sold to Vivalto Partners · (Recapitalization); Capza · via Artemid Senior Loans III · since 2022; Idia · via IDIA Small & Midcap · since 2023; Vivalto Partners · via Vivalto Partners Fund I · since 2023; Socadif · via SOCADIF.